<?xml version='1.0' encoding='utf-8'?>

<rss version="2.0">
  <channel>
    <title>The Federal Register</title>
    <link>http://thefederalregister.com/b.p/agency/National_Institutes_of_Health/2007-11-23/</link>
    <description>Daily Publications of Meetings and Rules Changes for the Federal Government</description>
    <pubDate>Tue, Dec 2 2008 11:00:00 GMT</pubDate>
    <lastBuildDate>Tue, Dec 2 2008 11:00:00 GMT</lastBuildDate>
    <webMaster>info@thefederalregister.com</webMaster>
    <item>
  <title><![CDATA[  Government-Owned Inventions; Availability for Licensing ]]></title>
  <link>http://thefederalregister.com/d.p/2007-11-23-E7-22821</link>
  <description><![CDATA[ The inventions listed below are owned by an agency of the U.S. 
Government and are available for licensing in the U.S. in accordance 
with 35 U.S.C. 207 to achieve expeditious commercialization of results 
of federallyfunded research and development. Foreign patent 
applications are filed on selected inventions to extend market coverage 
for companies and may also be available for licensing.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2007-11-23-E7-22821</guid>
  <pubDate>Fri, Nov 23 2007 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Public Teleconference Regarding Licensing and Collaborative  Research Opportunities for: ``Brother of the Regulator of]]></title>
  <link>http://thefederalregister.com/d.p/2007-11-23-E7-22820</link>
  <description><![CDATA[ Technology Summary</p><p>    The technology describes the discovery of a novel gene encoding the 
DNAbinding factor, ``Brother of the Regulator of Imprinted Sites'', 
BORIS, related to the unique, evolutionarily conserved, CTCF factor 
involved in regulation of genomic imprinting and cancer. Furthermore, 
it describes several splice variants of BORIS that translate into 
different proteins and antibodies of BORIS that can be used for  diagnosis and treatment of cancer.</p>
<h3>Technology Description</h3>
<p>    A very recent finding is that protein CTCF (expressed in all 
somatic tissues) binds, in a methylationdependent manner, to the 
imprinting control regions thus allowing somatic cells to distinguish 
functionally maternal from paternal alleles. The new factor, BORIS, 
shares with CTCF the same spectrum of DNA sequence specificity and it 
is normally expressed only in germ cells of human gonads (when patterns 
of gene imprinting are reestablished), but not in CTCFexpressing  somatic cells.</p><p>    Additionally, since cellgrowth <script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2007-11-23-E7-22820</guid>
  <pubDate>Fri, Nov 23 2007 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  National Institute of Environmental Health Sciences; Notice of  Closed Meeting]]></title>
  <link>http://thefederalregister.com/d.p/2007-11-23-07-5779</link>
  <description><![CDATA[
</p><p>    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following  meeting.</p><p>    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6). Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
</p><p>    Name of Committee: National Institute of Environmental Health 
Sciences Special Emphasis Panel, Genetic Environmental Training. </p><p>    Date: November 27, 2007.<br/> </p><p>    Time: 8:30 a.m. to 5 p.m.</p>
<h3>[[Page 65757]]</h3>
<p>    Agenda: To review and evaluate grant applications.
</p><p>    Place: Sheraton Imperial Hotel RTP, Sheraton Imperial Hotel,  4700 Emperor Blvd, Durham, NC 27703.</p><p>    Contact Person: Leroy<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2007-11-23-07-5779</guid>
  <pubDate>Fri, Nov 23 2007 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Center for Scientific Review; Notice of Closed Meeting ]]></title>
  <link>http://thefederalregister.com/d.p/2007-11-23-07-5778</link>
  <description><![CDATA[
</p><p>    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following  meeting.</p><p>    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets of commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
</p><p>    Name of Committee: Center for Scientific Review Special Emphasis  Panel, Endocrinology and Metabolism.<br/> </p><p>    Date: December 5, 2007.<br/> </p><p>    Time: 10 a.m. to 12 p.m.</p><p>    Agenda: To review and evaluate grant applications.
</p><p>    Place: National Institutes of Health, 6701 Rockledge Drive,  Bethesda, MD 20892, (Telephone Conference Call).</p><p>    Contact Person: Ann A. Jerkins, PhD, Scientific Revi<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2007-11-23-07-5778</guid>
  <pubDate>Fri, Nov 23 2007 11:00:00 GMT</pubDate>
</item>
</channel>
</rss>

